Shasun Pharmaceuticals Limited Sustainability Profile
Shasun Pharmaceuticals Limited, often referred to simply as Shasun, is a prominent player in the pharmaceutical industry, headquartered in India. Established in 1987, the company has made significant strides in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, catering to both domestic and international markets. With a strong presence in regions such as North America, Europe, and Asia, Shasun focuses on key therapeutic areas including anti-infectives, cardiovascular, and central nervous system disorders. The company is recognised for its commitment to quality and innovation, offering a diverse portfolio of products that stand out for their efficacy and safety. Shasun's dedication to research and development has positioned it as a trusted partner in the pharmaceutical sector, achieving notable milestones in regulatory approvals and collaborations. As a result, Shasun Pharmaceuticals Limited continues to enhance its market position, contributing to global health solutions.
DitchCarbon Score
How does Shasun Pharmaceuticals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shasun Pharmaceuticals Limited's score of 38 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shasun Pharmaceuticals Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Strides Pharma Science Limited, which may influence its climate commitments and emissions reporting. As of now, Shasun Pharmaceuticals has not set any documented reduction targets or climate pledges. The absence of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of formalising its climate strategy. Given the context of the pharmaceutical industry, it is essential for companies like Shasun Pharmaceuticals to develop robust climate commitments and emissions reduction strategies to align with global sustainability goals. The cascading data from Strides Pharma Science Limited may provide insights into broader corporate climate initiatives, but specific details regarding Shasun's own emissions and targets remain unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Scope 1 | 6,206,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 19,960,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | 00,000,000 | 00,000,000 |
How Carbon Intensive is Shasun Pharmaceuticals Limited's Industry?
How Carbon Intensive is Shasun Pharmaceuticals Limited's Location?
Shasun Pharmaceuticals Limited's Scope 3 Categories Breakdown
Shasun Pharmaceuticals Limited's Scope 3 emissions, which increased by 0% last year and increased by approximately 0% since 2024, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 68% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 44% of Scope 3 emissions.
Top Scope 3 Categories
Shasun Pharmaceuticals Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Shasun Pharmaceuticals Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
